Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT06298916
Recruiting
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Phase 1/2 · United States · 5 sites
Registry update: 12 Aug 2025
NCT07104955
Recruiting
Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety
Not applicable · United Kingdom · 1 site
Registry update: 5 Aug 2025
NCT06946225
Recruiting
ACTengine® IMA203 Combined With mRNA-4203
Phase 1 · United States · 4 sites
Registry update: 8 Jan 2026
NCT06967961
Recruiting
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Not applicable · France · 1 site
Registry update: 15 Jun 2026
NCT07751380
Recruiting
Multi-modular Chimeric Antigen Receptor T Cells tarGeting B7-H3 in Children, Teenage & Young Adult Sarcoma
Phase 1 · United Kingdom · 2 sites
Registry update: 7 Aug 2026
NCT06753136
Recruiting
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Not applicable · Italy · 1 site
Registry update: 13 Apr 2026
NCT07058064
Recruiting
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
Not applicable · United States · 1 site
Registry update: 15 Oct 2025
NCT06371768
Recruiting
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Not applicable · United States · 1 site
Registry update: 28 Jan 2026
NCT07145450
Recruiting
Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
Phase 1/2 · Germany, Denmark, Netherlands, Sweden · 10 sites
Registry update: 8 Jun 2026
NCT07227961
Recruiting
Activation Sarcoma: PROMIS and Mobility Evaluation in Sarcoma Patients
Not applicable · Canada, United States · 4 sites
Registry update: 2 Nov 2026
NCT07007273
Recruiting
Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma
Phase 2 · United States · 3 sites
Registry update: 1 Apr 2026
NCT07028086
Recruiting
VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
Phase 2 · China · 1 site
Registry update: 9 Jul 2025
NCT06198296
Recruiting
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Phase 1 · United States · 1 site
Registry update: 3 Nov 2025
NCT06797999
Recruiting
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Phase 1/2 · Belgium, Germany, France, United Kingdom, United States · 9 sites
Registry update: 11 Sept 2026
NCT06812052
Recruiting
Short Course Radiation Treatment for Patients With Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery
Phase 1 · United States · 1 site
Registry update: 14 Oct 2025
NCT07066982
Recruiting
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
Phase 1/2 · China · 1 site
Registry update: 15 Jul 2025
NCT06942143
Recruiting
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
Phase 1 · China · 1 site
Registry update: 3 Sept 2025
NCT06980259
Recruiting
Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma
Not applicable · China · 1 site
Registry update: 13 Oct 2026
NCT06839703
Recruiting
International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma
Phase 1 · Germany · 5 sites
Registry update: 2 Nov 2026
NCT06926283
Recruiting
A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors
Phase 1 · China · 4 sites
Registry update: 23 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.